Dutch medical equipment supplier Pie Medical Imaging (PMI) has introduced CAAS Qardia 2.0, a new version of its advanced echocardiography software platform.
The CAAS Qardia is designed to leverage artificial intelligence (AI) driven workflows for measuring important clinical parameters and ease-of-access.
It is an FDA-approved and CE marked platform that is deployed as in-hospital zero-footprint solution, which can be accessed from any PC within the hospital network.
The comprehensive and flexible off-cart echocardiography analysis feature is within reach with the new version, said the Dutch medical device company.
The CAAS Qardia enables viewing and analysis of myocardial strain analysis of left and right ventricles, stress-echo, diastology and (PISA) valve analysis, among others.
It automatically creates a report that contains clinically relevant parameters, and can be shared with colleagues, said the company.
Pie Medical Imaging managing director Rene Guillaume said “With CAAS Qardia 2.0 Pie Medical Imaging underscores its commitment to simplify the cardiologist’s daily practice with accurate and easy-to-use analysis tools.”
According to the company, foreshortening of the heart’s views negatively affects functional measurements including myocardial strain, which is frequently unnoticed.
Its CAAS Qardia is available in a server-based or classical stand-alone setup, and counteracts this by providing to the user quality control indices.
Healthcare institutions can use the vendor-neutral platform for all their multi-vendor echocardiography image sets.
Pie Medical Imaging is focused on analysis and visualisation of cardiovascular images, and hosts the global sales for the CAAS and 3mensio product lines.
The company, together with 3mensio Medical Imaging, is a part of the Esaote Group, which provides biomedical equipment, including the ultrasound, dedicated MRI, and Medical IT devices.
